And there it is - patent issued: https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=exopharm&OS=exopharm&RS=exopharm
Expecting this to accelerate deals/partnership talks in the new year.
Of course, continued progress across the industry in the development of exosome therapeutics is also key to demand for Exopharm's LEAP technology.
